June 22, 2026 Beijing Review: Connecting through code and culture Beijing Review: Connecting through code and culture Beijing Review: Connecting through code and culture Read More
June 22, 2026 LG Display OLED becomes world’s first to achieve “Perfect Color/Brightness” certification LG Display OLED becomes world's first to achieve "Perfect Color/Brightness" certification LG Display OLED becomes world's first to achieve "Perfect Color/Brightness" certification Read More
June 22, 2026 Annie Estrin Launches Public Awareness Campaign After a Paraiso Miami Swim Week Injury Annie Estrin Launches Public Awareness Campaign After a Paraiso Miami Swim Week Injury Annie Estrin Launches Public Awareness Campaign After a Paraiso Miami Swim ... Read More
June 22, 2026 La poudre fine de polyoxyméthylène (POM) DURAST® de Daicel retenue pour la fabrication d’un lubrifiant innovant sous forme de bâtonnet La poudre fine de polyoxyméthylène (POM) DURAST® de Daicel retenue pour la fabrication d'un lubrifiant innovant sous forme de bâtonnet La poudre fine de polyoxyméthylène (POM) DURAST® de Daicel retenue pour ... Read More
June 22, 2026 Circles, Greyskies, and HCLTech Collaborate in TM Forum Catalyst Program to Accelerate AI-led Autonomous Network Operations Circles, Greyskies, and HCLTech Collaborate in TM Forum Catalyst Program to Accelerate AI-led Autonomous Network Operations Circles, Greyskies, and HCLTech Collaborate in TM Forum Catalyst Program to ... Read More
June 22, 2026 Hugel showcases global K-aesthetics momentum at AMWC KOREA Hugel showcases global K-aesthetics momentum at AMWC KOREA Hugel showcases global K-aesthetics momentum at AMWC KOREA Read More
June 22, 2026 Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical ... Read More
June 22, 2026 LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and ... Read More
June 22, 2026 ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit Read More
June 22, 2026 Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ... Read More